ABSTRACT
What does it take to successfully lead a Division of Geriatrics? Is it the same skill set today as it was two or three decades ago? Is it the same for each chief, given the wide spectrum of geriatrics programs across our nation? Early leaders in our field showcased and role-modeled the career and job satisfaction that accompanies leadership of traditional geriatrics academic programs. This has been well articulated in past issues of the Journal of the American Geriatrics Society in articles by Dr William Hazzard and Dr Greg Sachs. How can we develop the next generation of geriatrics program leaders and ensure their success? Developed as a conversation between three generations of geriatrics division chiefs, this reflective article offers a shared perspective on what is required for success in advancing as a leader in our field and wholeheartedly enjoying the best job in the world.
Subject(s)
Clinical Competence/standards , Geriatrics/trends , Interprofessional Relations , Leadership , Academic Medical Centers , Career Choice , Humans , Mentoring/standards , United StatesABSTRACT
OBJECTIVES: To determine how often outpatient physician visits detect sleep apnea (SA) in older persons in the United States. DESIGN: Retrospective Analysis. SETTING: US non hospital and hospital based clinics. PARTICIPANTS: US physicians. MEASUREMENTS: National Ambulatory Medical Care Survey and National Hospital Ambulatory Medical Care Survey data from 1993 to 2011 were used to assess the frequency of physicians' coding diagnoses of SA in persons aged 65 and older. Which specialties are most likely to report SA, the most-common comorbid conditions reported with SA, and the likelihood of reporting SA in patient visits for dementia and preoperative care were assessed. RESULTS: From 1993 to 2011, physicians reported SA in 0.3% of all office visits in persons aged 65 and older. SA reported in visits increased from 130,000 in 1993 to 2,070,000 in 2011, with an annual per capita visit reporting rate of 0.07% to 0.74%. In older populations, the proportion of documented SA visits by specialists rose, and that of primary care providers decreased. Older adults with a diagnosis of SA had higher average number of comorbidities than those without SA (1.8 vs 1.3). Reporting SA was low in visits with a diagnosis of dementia and classified as a preoperative visits. CONCLUSION: In two nationwide surveys, SA reporting by physicians in elderly adults was 16 as greater in 2001 as in 1993, although reporting of SA remains infrequent (<1% of visits) even in vulnerable populations.
Subject(s)
Aging , Physicians, Primary Care/statistics & numerical data , Sleep Apnea Syndromes/diagnosis , Aged , Aged, 80 and over , Humans , Retrospective Studies , Specialization/statistics & numerical data , United StatesSubject(s)
Breast Neoplasms/complications , Breast Neoplasms/pathology , Hospice Care , Neoplasm Recurrence, Local/complications , Neoplasm Recurrence, Local/pathology , Postpoliomyelitis Syndrome/complications , Right to Die , Aged, 80 and over , Female , Humans , Neoplasm Invasiveness , Neoplasm Staging , Postpoliomyelitis Syndrome/rehabilitation , SiblingsSubject(s)
Biomedical Research/trends , Forecasting , Geriatrics/trends , Societies, Medical , Humans , United States/epidemiologySubject(s)
Correction of Hearing Impairment/methods , Health Priorities , Health Services Accessibility , Hearing Loss/rehabilitation , Hearing , Academies and Institutes , Adult , Correction of Hearing Impairment/economics , Correction of Hearing Impairment/instrumentation , Engineering , Hearing Aids/economics , Humans , Medicine , National Academy of Sciences, U.S. , Patient Education as Topic , United StatesABSTRACT
Older adults are more likely to have chronic wounds than younger people, and the effect of chronic wounds on quality of life is particularly profound in this population. Wound healing slows with age, but the basic biology underlying chronic wounds and the influence of age-associated changes on wound healing are poorly understood. Most studies have used in vitro approaches and various animal models, but observed changes translate poorly to human healing conditions. The effect of age and accompanying multimorbidity on the effectiveness of existing and emerging treatment approaches for chronic wounds is also unknown, and older adults tend to be excluded from randomized clinical trials. Poorly defined outcomes and variables; lack of standardization in data collection; and variations in the definition, measurement, and treatment of wounds also hamper clinical studies. The Association of Specialty Professors, in conjunction with the National Institute on Aging and the Wound Healing Society, held a workshop, summarized in this article, to explore the current state of knowledge and research challenges, engage investigators across disciplines, and identify research questions to guide future study of age-associated changes in chronic wound healing.
Subject(s)
Skin Ulcer/therapy , Wound Healing , Aged , Biomedical Research/trends , Chronic Disease , Forecasting , Humans , Surveys and QuestionnairesABSTRACT
The incidence of chronic wounds is increased among older adults, and the impact of chronic wounds on quality of life is particularly profound in this population. It is well established that wound healing slows with age. However, the basic biology underlying chronic wounds and the influence of age-associated changes on wound healing are poorly understood. Most studies have used in vitro approaches and various animal models, but observed changes translate poorly to human healing conditions. The impact of age and accompanying multi-morbidity on the effectiveness of existing and emerging treatment approaches for chronic wounds is also unknown, and older adults tend to be excluded from randomized clinical trials. Poorly defined outcomes and variables, lack of standardization in data collection, and variations in the definition, measurement, and treatment of wounds also hamper clinical studies. The Association of Specialty Professors, in conjunction with the National Institute on Aging and the Wound Healing Society, held a workshop, summarized in this paper, to explore the current state of knowledge and research challenges, engage investigators across disciplines, and identify key research questions to guide future study of age-associated changes in chronic wound healing.
Subject(s)
Aging , Anti-Infective Agents/administration & dosage , Electric Stimulation Therapy/methods , Negative-Pressure Wound Therapy/methods , Skin Ulcer/therapy , Tissue Engineering/methods , Administration, Topical , Age Factors , Aged , Aged, 80 and over , Animals , Canada/epidemiology , Chronic Disease , Comorbidity , Disease Progression , Female , Humans , Male , Mice , Quality of Life , Skin Ulcer/immunology , Skin Ulcer/pathology , United States/epidemiology , Wound HealingABSTRACT
The prevalence of diabetes increases with age, driven in part by an absolute increase in incidence among adults aged 65 years and older. Individuals with diabetes are at higher risk for cardiovascular disease, and age strongly predicts cardiovascular complications. Inflammation and oxidative stress appear to play some role in the mechanisms underlying aging, diabetes, cardiovascular disease, and other complications of diabetes. However, the mechanisms underlying the age-associated increase in risk for diabetes and diabetes-related cardiovascular disease remain poorly understood. Moreover, because of the heterogeneity of the older population, a lack of understanding of the biology of aging, and inadequate study of the effects of treatments on traditional complications and geriatric conditions associated with diabetes, no consensus exists on the optimal interventions for older diabetic adults. The Association of Specialty Professors, along with the National Institute on Aging, the National Institute of Diabetes and Digestive and Kidney Diseases, the National Heart, Lung, and Blood Institute, and the American Diabetes Association, held a workshop, summarized in this Perspective, to discuss current knowledge regarding diabetes and cardiovascular disease in older adults, identify gaps, and propose questions to guide future research.
Subject(s)
Aging , Cardiovascular Diseases/etiology , Diabetes Complications/pathology , Adult , Aged , Blood Glucose , Cardiovascular Diseases/epidemiology , Diabetes Complications/epidemiology , Humans , Hyperglycemia , Middle Aged , United States/epidemiology , Young AdultSubject(s)
Academic Medical Centers/history , Geriatrics/history , Program Development , Aged , History, 20th Century , Humans , United StatesSubject(s)
Geriatrics , Longevity , Professional Competence , Age Factors , Aged , Burnout, Professional , Humans , Physicians , Societies, Scientific , United StatesABSTRACT
Aging kidneys undergo structural and functional changes that decrease autoregulatory capacity and increase susceptibility to acute injury. Acute kidney injury associates with duration and location of hospitalization, mortality risk, progression to chronic kidney disease, and functional status in daily living. Definition and diagnosis of acute kidney injury are based on changes in creatinine, which is an inadequate marker and might identify patients when it is too late. The incidence of acute kidney injury is rising and increases with advancing age, yet clinical studies have been slow to address geriatric issues or the heterogeneity in etiologies, outcomes, or patient preferences among the elderly. Here we examine some of the current literature, identify knowledge gaps, and suggest potential research questions regarding acute kidney injury in older adults. Answering these questions will facilitate the integration of geriatric issues into future mechanistic and clinical studies that affect management and care of acute kidney injury.
Subject(s)
Acute Kidney Injury/physiopathology , Aging/physiology , Acute Kidney Injury/complications , Acute Kidney Injury/diagnosis , Aged , Aged, 80 and over , Biomarkers/blood , Creatinine/blood , Female , Humans , Kidney Failure, Chronic/epidemiology , Male , Risk FactorsABSTRACT
Idiopathic pulmonary fibrosis (IPF), a heterogeneous disease with respect to clinical presentation and rates of progression, disproportionately affects older adults. The diagnosis of IPF is descriptive, based on clinical, radiologic, and histopathologic examination, and definitive diagnosis is hampered by poor interobserver agreement and lack of a consensus definition. There are no effective treatments. Cellular, molecular, genetic, and environmental risk factors have been identified for IPF, but the initiating event and the characteristics of preclinical stages are not known. IPF is predominantly a disease of older adults, and the processes underlying normal aging might significantly influence the development of IPF. Yet, the biology of aging and the principles of medical care for this population have been typically ignored in basic, translational, or clinical IPF research. In August 2009, the Association of Specialty Professors, in collaboration with the American College of Chest Physicians, the American Geriatrics Society, the National Institute on Aging, and the National Heart, Lung, and Blood Institute, held a workshop, summarized herein, to review what is known, to identify research gaps at the interface of aging and IPF, and to suggest priority areas for future research. Efforts to answer the questions identified will require the integration of geriatrics, gerontology, and pulmonary research, but these efforts have great potential to improve care for patients with IPF.
Subject(s)
Aging/physiology , Biomedical Research/organization & administration , Geriatrics/organization & administration , Health Priorities/organization & administration , Idiopathic Pulmonary Fibrosis , Aged , Humans , Idiopathic Pulmonary Fibrosis/diagnosis , Idiopathic Pulmonary Fibrosis/etiology , Idiopathic Pulmonary Fibrosis/therapy , Middle AgedSubject(s)
Health Services Misuse , Hospitalization , Nursing Homes/organization & administration , Total Quality Management/organization & administration , Aged , Continuity of Patient Care , Health Services Misuse/statistics & numerical data , Hospitalization/statistics & numerical data , Humans , Nursing Staff/education , Nursing Staff/supply & distribution , Utilization ReviewABSTRACT
Goals for immunization in older adults may differ from those in young adults and children, in whom complete prevention of disease is the objective. Often, reduced hospitalization and death but also averting exacerbation of underlying chronic illness, functional decline, and frailty are important goals in the older age group. Because of the effect of age on dendritic cell function, T cell-mediated immune suppression, reduced proliferative capacity of T cells, and other immune responses, the efficacy of vaccines often wanes with advanced age. This article summarizes the discussion and proceedings of a workshop organized by the Association of Specialty Professors, the Infectious Diseases Society of America, the American Geriatrics Society, the National Institute on Aging, and the National Institute of Allergy and Infectious Diseases. Leading researchers and clinicians in the fields of immunology, epidemiology, infectious diseases, geriatrics, and gerontology reviewed the current status of vaccines in older adults, identified knowledge gaps, and suggest priority areas for future research. The goal of the workshop was to identify what is known about immunizations (efficacy, effect, and current schedule) in older adults and to recommend priorities for future research. Investigation in the areas identified has the potential to enhance understanding of the immune process in aging individuals, inform vaccine development, and lead to more-effective strategies to reduce the risk of vaccine-preventable illness in older adults.